IL118103A - Composition of thymus factor protein comprising a lysine-rich histone factor capable of precipitating beta-, alpha1-, alpha2-macroglobulins of a healthy mammal - Google Patents
Composition of thymus factor protein comprising a lysine-rich histone factor capable of precipitating beta-, alpha1-, alpha2-macroglobulins of a healthy mammalInfo
- Publication number
- IL118103A IL118103A IL11810396A IL11810396A IL118103A IL 118103 A IL118103 A IL 118103A IL 11810396 A IL11810396 A IL 11810396A IL 11810396 A IL11810396 A IL 11810396A IL 118103 A IL118103 A IL 118103A
- Authority
- IL
- Israel
- Prior art keywords
- macroglobulins
- alpha1
- alpha2
- lysine
- factor
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 210000001541 thymus gland Anatomy 0.000 title abstract 2
- 108010033040 Histones Proteins 0.000 title 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 title 1
- 239000004472 Lysine Substances 0.000 title 1
- 241000124008 Mammalia Species 0.000 title 1
- 230000001376 precipitating effect Effects 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 208000030507 AIDS Diseases 0.000 abstract 2
- 206010001513 AIDS related complex Diseases 0.000 abstract 2
- 241000725303 Human immunodeficiency virus Species 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 238000002255 vaccination Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- AIDS & HIV (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43188395A | 1995-05-01 | 1995-05-01 | |
US48554895A | 1995-06-07 | 1995-06-07 | |
US64193696A | 1996-05-01 | 1996-05-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL118103A0 IL118103A0 (en) | 1997-03-18 |
IL118103A true IL118103A (en) | 2000-02-29 |
Family
ID=27411755
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11810396A IL118103A (en) | 1995-05-01 | 1996-05-01 | Composition of thymus factor protein comprising a lysine-rich histone factor capable of precipitating beta-, alpha1-, alpha2-macroglobulins of a healthy mammal |
Country Status (11)
Country | Link |
---|---|
EP (2) | EP0826003B1 (xx) |
CN (1) | CN1221568C (xx) |
AT (1) | ATE205221T1 (xx) |
BG (1) | BG64056B1 (xx) |
CA (1) | CA2220347C (xx) |
DE (1) | DE69615015T2 (xx) |
DK (1) | DK0826003T3 (xx) |
EA (1) | EA001100B1 (xx) |
ES (1) | ES2163028T3 (xx) |
HK (1) | HK1009457A1 (xx) |
IL (1) | IL118103A (xx) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102008057479A1 (de) | 2008-11-14 | 2010-05-20 | Bernhard, Stefan, Dr. | Vorrichtung und Verfahren zur Stärkung des Immunsystems durch Langzeitstimulation der Thymusdrüse |
CN112782398A (zh) * | 2020-12-28 | 2021-05-11 | 重庆生命知源科技有限公司 | 一种微量蛋白免疫印迹检测方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4415553A (en) * | 1973-08-06 | 1983-11-15 | Dso "Pharmachim" | Compositions, processes for their preparation and method for treatment of neoplasms |
US4818763A (en) * | 1984-01-12 | 1989-04-04 | Volker Rusch | Biologically active substance with hormonal properties, production process thereof and utilization of histones for medical purposes |
AU2800389A (en) * | 1987-12-02 | 1989-07-05 | Regents Of The University Of California, The | Aids-related anti-t-cell antibody test |
GB9209874D0 (en) * | 1992-05-07 | 1992-06-24 | Ml Lab Plc | Pharmaceutical compositions |
-
1996
- 1996-05-01 AT AT96920118T patent/ATE205221T1/de not_active IP Right Cessation
- 1996-05-01 ES ES96920118T patent/ES2163028T3/es not_active Expired - Lifetime
- 1996-05-01 CA CA002220347A patent/CA2220347C/en not_active Expired - Fee Related
- 1996-05-01 IL IL11810396A patent/IL118103A/xx not_active IP Right Cessation
- 1996-05-01 DK DK96920118T patent/DK0826003T3/da active
- 1996-05-01 EA EA199700353A patent/EA001100B1/ru not_active IP Right Cessation
- 1996-05-01 EP EP96920118A patent/EP0826003B1/en not_active Expired - Lifetime
- 1996-05-01 CN CNB961952032A patent/CN1221568C/zh not_active Expired - Fee Related
- 1996-05-01 DE DE69615015T patent/DE69615015T2/de not_active Expired - Fee Related
- 1996-05-01 EP EP00125954A patent/EP1104770A3/en not_active Withdrawn
-
1997
- 1997-11-28 BG BG102083A patent/BG64056B1/bg unknown
-
1998
- 1998-09-03 HK HK98110415A patent/HK1009457A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE69615015T2 (de) | 2002-06-27 |
IL118103A0 (en) | 1997-03-18 |
CN1189839A (zh) | 1998-08-05 |
EP1104770A3 (en) | 2001-06-27 |
DK0826003T3 (da) | 2001-11-26 |
BG64056B1 (bg) | 2003-11-28 |
CA2220347A1 (en) | 1996-11-07 |
EA199700353A1 (ru) | 1998-04-30 |
CN1221568C (zh) | 2005-10-05 |
BG102083A (en) | 1998-10-30 |
EP1104770A2 (en) | 2001-06-06 |
EA001100B1 (ru) | 2000-10-30 |
EP0826003B1 (en) | 2001-09-05 |
EP0826003A1 (en) | 1998-03-04 |
HK1009457A1 (en) | 1999-06-04 |
ATE205221T1 (de) | 2001-09-15 |
ES2163028T3 (es) | 2002-01-16 |
DE69615015D1 (de) | 2001-10-11 |
CA2220347C (en) | 2003-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200000596A1 (ru) | Tat вич-1 или его производные для профилактической и лечебной вакцинации | |
BR1101088A (pt) | Proteìna g do vìrus sincicial respiratório não glicosilada isolada e substancialmente pura | |
NO20025153L (no) | Fremgangsmåter og sammensetninger for å påvirke formering av HIV-1, HIV-2 og SIV | |
WO2002014362A3 (en) | A hepatitis c virus non-structural ns3/4a fusion gene | |
WO2002068654A3 (es) | Poxvirus recombinantes para proteinas quimericas del virus de la inmunodeficiencia humana | |
EP1702068A4 (en) | APPROVED INTERLEUKINE-10 AND ITS USES | |
IL118103A (en) | Composition of thymus factor protein comprising a lysine-rich histone factor capable of precipitating beta-, alpha1-, alpha2-macroglobulins of a healthy mammal | |
IL115074A0 (en) | A novel salt of (1s,4r)-cis-4--Ú2-amino-6-(cyclopropylamino)-9h-purin-9-yl-¾- 2-cyclopentene-1-methanol solvates thereof their preparation and pharmaceutical compositions containing them | |
CA2181590A1 (en) | Peptomers with enhanced immunogenicity | |
PT1417222E (pt) | Polipéptidos isolados baseados no epítopo neutralizante da proteína p17 de vih, úteis como vacinas, e anticorpos antip17 neutralizantes que reconhecem especificamente o referido polipéptido neutralizante | |
EP0719281B1 (en) | Multiple branch peptide constructions for use against hiv | |
US5622933A (en) | Multiple branch peptide constructions for use against HIV | |
BR9608837A (pt) | "composição obtida de células para detectar uma infecção por vìrus da imunodeficiência humana, aparelho, kit e métodos para sua detecção, purificação da proteìna e sua obtenção e tratamento do ser humano" | |
CA2057612A1 (en) | Selected peptides of the group-specific antigen (gag) of human immunodeficiency virus (hiv), the preparation and use thereof | |
AP9901615A0 (en) | Multiple branch peptide constructions. | |
IL102815A (en) | Pharmaceutical compositions for the treatment of infection caused by the human immunodeficiency virus | |
ATE284709T1 (de) | Virale chimären aus caev und hiv-1 genetischen elementen | |
CA2171531C (en) | Multiple branch peptide constructions for use against hiv | |
EP0491888A4 (en) | Immunotherapeutic compositions for treating and preventing aids, arc and hiv infection | |
WO2002026253A1 (fr) | Vaccin contre le sida, son procede de preparation et ses applications | |
EP0323424A3 (en) | Peptide corresponding to hiv-env 583-599, and analogs thereof and applications of the peptides | |
JP3725899B6 (ja) | Hivに対して使用するための多分岐ペプチド構築物 | |
WO2002068464A3 (de) | Fusionsprotein zum blocken des hiv nef-proteins | |
ES2021943A6 (es) | Procedimiento para la sintesis de peptidos para neutralizar la infectividad del virus del sida (vhs) | |
KR20040000401A (ko) | Hiv 바이러스에 대한 천연 항체 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |